The ins and outs of caveolar signaling. m2 muscarinic cholinergic receptors and eNOS activation versus neuregulin and ErbB4 signaling in cardiac myocytes

Annals of the New York Academy of Sciences

Volumn 874, Issue , 1999, Pages 11-19

  Feron, Olivier ^b   Zhao, You Yang ^a   Kelly, Ralph A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN; LIPID; MUSCARINIC M2 RECEPTOR; NEU DIFFERENTIATION FACTOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

BLOOD VESSEL INJURY; BLOOD VESSEL PERMEABILITY; CELL MEMBRANE; CONFERENCE PAPER; CORONARY BLOOD VESSEL; ENDOCARDIUM; ENDOTHELIUM CELL; ENZYME ACTIVATION; HEART MUSCLE CELL; MYRISTYLATION; ONCOGENE ERB B4; PALMITOYLATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE TONE; THROMBOCYTE ADHESION; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

EID: 0005714843     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb09220.x     Document Type: Conference Paper

References (39)

1. 1. KELLY, R.A., J.-L. BALLIGAND & T.W. SMITH. 1996. Nitric oxide and cardiac function. Circ. Res. 79: 363-380.
2. 2. KELLY, R.A. & X. HAN. 1997. Nitrovasodilators have (small) direct effects on cardiac contractility. Is this important? Circulation 96: 2493-2495.
3. 3. FERON, O., L. BELHASSEN, L. KOBZIK, T.W. SMITH, R.A. KELLY & T. MICHEL. 1996. Endothelial nitric oxide synthase targeting to caveolae: specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J. Biol. Chem. 271: 22810-22814.
4. 4. MICHEL, T. & O. FERON. 1997. Nitric oxide synthases: which, where, how, and why? J. Clin. Invest. 100: 1-7.
5. 5. ISHIKAWA, H. 1968. Formation of elaborate networks of T-system tubules in cultured skeletal muscle with special reference to the T-system formation. J. Cell Biol. 38: 51-66.
6. 6. PARTON, R.G., M. WAY, N. ZORZI & E. STANG. 1997. Caveolin-3 associates with developing T-tubules during muscle differentiation. J. Cell Biol. 136: 137-154.
7. 7. MESZAROS, L.G., I. MINAROVIC & A. ZABRADNIKOVA. 1996. Inhibition of the skeletal muscle ryanodine receptor calcium release channel by nitric oxide. FEBS Lett. 380: 49-52.
8. 8. ZAHRADNIKOVA, A., I. MINAROVIC, R.C. VENEMA & L.G. MESZAROS. 1997. Inactivation of the cardiac ryanodine receptor calcium release channel by nitric oxide. Cell Calcium 22: 447-453.
9. 9. XU, L., J.P. EU, G. MEISSNER & J.S. STAMLER. 1998. Activation of the cardiac calcium release channel (ryanodine receptor) by poly-s-nitrosylation. Science 279: 234-237.
10. 10. MESZAROS, L.G. & V. LUKYANENKO. 1998. Nitric oxide reduces spontaneous calcium release activity in isolated rat ventricular myocytes - a confocal Ca-imaging study. Presented at the 42nd Annual Meeting of the Biophysical Society. Kansas City, MO, USA, 1998. Abstract submitted.
11. 11. STOYANOVSKY, D., T. MURPHY, P.R. ANNO, Y.-M. KIM & G. SALAMA. 1997. Nitric oxide activates skeletal and cardiac ryanodine receptors. Cell Calcium 21: 19-29.
12. 12. ELVAN, A., M. RUBART & O.P. ZIPES. 1997. NO modulates autonomic effects on sinus discharge rate and AV nodal conduction in open-chest dogs. Am. J. Physiol. 272: H263-H271.
13. 13. SHIMONI, Y., X. HAN, D. SEVERSON & W.R. GILES. 1996. Mediation by nitric oxide of the indirect effects of adenosine on calcium current in rabbit heart pacemaker cells. Br. J. Pharmacol. 119: 1463-1469.
14. 14. MARTYNYUK, A.G., K.A. KANE, S.M. COBBE & A.C. RANKIN. 1996. Nitric oxide mediates the anti-adrenergic effect of adenosine on calcium current in isolated rabbit atrioventricular nodal cells. Pflugers Arch. 431: 452-457.
15. 15. CAMPBELL, D.L., J.S. STAMLER & H.C. STRAUSS. 1996. Redox modulation of L-type calcium channels in ferret ventricular myocytes: dual mechanism regulation by nitric oxide and S-nitrosothiols. J. Gen. Physiol. 108: 277-293.
16. Ca-L is absent in mice with targeted disruption of endothelial nitric oxide synthase (eNOS). Proc. Natl. Acad. Sci. USA 95: 6510-6515.
17. 17. HUANG, P.L., Z. HUANG, H. MASHIMO, K.D. BLOCH, M.A. MOSKOWITZ, J.A. BEVAN & M.C. FISHMAN. 1995. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377: 239-242.
18. 18. MOROI, M., L. ZHANG, T. YASUDA, R. VIRMANI, H.K. GOLD, M. C. FISHMAN & P. L. HUANG. 1998. Interaction of genetic deficiency of endothelial nitric oxide, gender, and pregnancy in vascular response to injury in mice. J. Clin. Invest. 101: 1225-1232.
19. 19. RUDIC, R.D., E.G. SHESELY, N. MAEDA, O. SMITHIES, S.S. SEGAL & W.C. SESSA. 1998. Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. J. Clin. Invest. 101: 731-736.
20. 20. BELHASSEN, L., R.A. KELLY, T.W. SMITH & J.-L. BALLIGAND. 1996. Nitric oxide synthase (NOS3) and contractile responsiveness to adrenergic and cholinergic agonists in the heart: regulation of NOS3 transcription in vitro and in vivo by cAMP in rat cardiac myocytes. J. Clin. Invest. 97: 1908-1915.
21. 21. BELHASSEN, L., O. FERON, D.M. KAYE, T. MICHEL & R.A. KELLY. 1997. Regulation by cAMP of post-translational processing and subcellular targeting of endothelial nitric oxide synthase (type 3) in cardiac myocytes. J. Biol. Chem. 272: 11198-11204.
22. 22. FERON, O., T.W. SMITH, T. MICHEL & R.A. KELLY. 1997. Dynamic targeting of the agonist-stimulated m2 muscarinic acetylcholine receptor to caveolae in cardiac myocytes. J. Biol. Chem. 272: 17744-17748.
23. 23. MARCHIONNI, M.A. 1995. neu tack on neuregulin. Nature 378: 334-335.
24. 24. MEYER, D. & C. BIRCHMEIER. 1995. Multiple essential functions of neuregulin in development. Nature 378: 386-390.
25. 25. LEE, K.-F., H. SIMON, H. CHEN, B. BATES, M.-C. HUNG & C. HAUSER. 1995. Requirement for neuregulin receptor erbB2 on neural and cardiac development. Nature 378: 394-398.
26. 26. GASSMAN, M., F. CASAGRANDA, D. ORIOLI, H. SIMON, C. LAL, R. KLEIN & G. LEMKE. 1995. Aberrant neural and cardiac development in mice lacking the erbB4 neuregulin receptor. Nature 378: 390-394.
27. 27. BURDEN, S. & Y. YARDEN. 1997. Neuregulins and their receptors: a versatile signaling module in organogenesis and oncogenesis. Neuron 18: 847-855.
28. 28. CHANG, H., D.J. RIESE II, W. GILBERT, D.F. STERN & U.J. MCMAHAN. 1997. Ligands for ErbB-family receptors encoded by a neuregulin-like gene. Nature 387: 509-512.
29. 29. CARRAWAY, K.L. III, J.L. WEBER, M.J. UNGER, J. LEDESMA, N. YU, M. GASSMANN & C. LAI. 1997. Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases. Nature 387: 512-516.
30. 30. ZHANG, D., M.X. SLIWKOWSKI, M. MARK, G. FRANTZ, R. AKITA, Y. SUN, K. HILLAN, C. CROWLEY, J. BRUSH & P.J. GODOWSKI. 1997. Neuregulin-3 (NRG3): a novel neural tissue-enriched protein that binds and activates ErbB4. Proc. Natl. Acad. Sci. USA 94: 9562-9567.
31. 31. PERRELLA, M.A.T. MAKI, S. PRASAD, D. PIMENTAL, K. SINGH, N. TAKAHASHI, M. YOSHIZUMI, A. ALALI, S. HIGASHIYAMA, R.A. KELLY, M. LEE & T.W. SMITH. 1994. Regulation of heparin-binding epidermal growth factor-like growth factor mRNA levels by hypertrophic stimuli in neonatal and adult rat cardiac myocytes. J. Biol. Chem. 269: 27045-27050.
32. 32. QIU, Y., R. LAKSHMESWARI & H.-J. KUNG. 1998. Requirement of ErbB2 for signaling by interleukin-6 in prostate carcinoma cells. Nature 393: 83-85.
33. 33. ZHAO, Y.-Y., D.R. SAWYER, R. R. BALIGA, D.J. OPEL, X. HAN, M.A. MARCHIONNI & R.A. KELLY. 1998. Neuregulins promote survival and growth of cardiac myocytes. Persistence of ErbB2 and ErbB4 expression in neonatal and adult ventricular myocytes. J. Biol. Chem. 273: 10261-10269.
34. 34. VECCHI, M., J. BAULIDA & G. CARPENTER. 1996. Selective cleavage of the heregulin receptor ErbB-4 by protein kinase C activation. J. Biol. Chem. 271: 18989-18995.
35. 35. VECCHI, M. & G. CARPENTER. 1997. Constitutive proteolysis of the ErbB-4 receptor tyrosine kinase by a unique, sequential mechanism. J. Cell Biol. 139: 995-1003.
36. 36. OKAMOTO, T., A. SCHLEGEL, P.E. SCHERER & M. P. LISANTI. 1998. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J. Biol. Chem. 273: 5419-5422.
37. 37. COUET, J., M. SARGIACOMO & M.P. LISANTI. 1997. Interaction of a receptor tyrosine kinase, EGF-R, with caveolins - caveolin. Binding negatively regulates tyrosine and serine/threonine kinase activities. J. Biol. Chem. 272: 30429-30438.
38. 38. LIU, P.S., Y.S. YING, Y.G. KO & R.G.W. ANDERSON. 1996. Localization of platelet-derived growth factor-stimulated phosphorylation. Cascade to caveolae. J. Biol. Chem. 271: 10299-10303.
39. 39. GARCIA-CARDENA, G., P. MARTASEK, B.S.S. MASTERS, P.M. SKIDD, J. COUET, S.W. LI, M.P. LISANTI & W.C. SESSA. 1997. Dissecting the interaction between nitric oxide synthase (NOS) and caveolin - Functional significance of the NOS caveolin binding domain in vivo. J. Biol. Chem. 272: 25437-25440.